SCHEMBL29508609

SCHEMBL29508609

CCOC(=O)C12CCN(C(=O)OC(C)(C)C)CC1N(Cc1ccccc1)CC2=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.44
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
OPRD1 P41143 2/20 0.42
OPRK1 P41145 1/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
LMNA P02545 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.40
BRD4 O60885 1/20 0.39
SIGMAR1 Q99720 2/20 0.39
GAA P10253 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22950325 0.91 GPR119 (0.41) GPR119CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL29662060 0.91 GPR119 (0.41) GPR119CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL20520705 0.79 OPRD1 (0.42) GPR119CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL28692347 0.75 CYP2D6 (0.41) CYP3A4CYP2D6CYP2C19LMNAMEN1
SCHEMBL27619332 0.74 GPR119 (0.48) GPR119CYP2C19JAK2JAK1MEN1
SCHEMBL30989078 0.74 OPRD1 (0.53) CYP3A4CYP2D6CYP2C9CYP2C19OPRD1
SCHEMBL16862236 0.72 CYP2D6 (0.51) GPR119CYP3A4CYP2D6CYP2C19OPRD1
SCHEMBL965515 0.72 LMNA (0.62) LMNAMEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL30989110 0.72 OPRD1 (0.50) GPR119CYP3A4CYP2D6CYP2C19OPRD1
SCHEMBL9345760 0.72 OPRD1 (0.46) GPR119OPRD1OPRK1JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003997-A1 DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2022-06-01 EP disclosed
CN-114174300-A Dihydropyrimidine derivatives and their use in the treatment of HBV infection or HBV-induced diseases 杨森科学爱尔兰无限公司 2022-03-11 CN disclosed